Table 4

Median of the JADAS10 parameters AJC, physician’s VAS, parent/patient VAS and ESR in patient classified as CID, LDA, MDA and HDA according to cut-off values presented in the present study and those proposed earlier by Consolaro et al12 18 19

Oligoarticular diseaseAJC median (range)Parent/patient VAS median (range)Physician’s VAS median (range)ESR median (range)
CID
JADAS10 ≤0.5 (n=77)0 (0)0.0 (0.0–0.5)0.0 (0.0–1.0)5 (1–20)
JADAS10 ≤1.018 (n=89)0 (0–1)0.0 (0.0–1.0)0.0 (0.0–1.0)5 (1–20)
JADAS10 ≤1.519 (n=99)0 (0–1)0.0 (0.0–1.5)0.0 (0.0–1.0)5 (1–20)
LDA
JADAS10 0.6–3.8 (n=60)0 (0–2)0.0 (0.0–3.6)0.5 (0.0–3.0)4 (2–21)
JADAS10 1.1–2.018 (n=17)0 (0–1)1.0 (0.0–2.0)0.2 (0.0–1.0)4 (2–11)
JADAS10 1.6–3.919 (n=38)0 (0–2)1.5 (0.0–3.6)0.8 (0.0–3.0)4 (2–21)
MDA
JADAS10 3.9–6.6 (n=28)1 (0–3)2.1 (0.0–5.4)1.6 (0.0–3.0)8 (2–31)
JADAS10 2.1–4.218 (n=35)0 (0–2)1.6 (0.0–4.0)1 (0.0–3.0)4 (2–21)
JADAS10 4.0–16.419 (n=46)1 (0–3)3.2 (0.0–10.0)1.9 (0.0–5.0)5 (2–31)
HDA
JADAS10 >6.6 (n=18)1 (0–3)5.2 (2.6–10.0)2.0 (1.0–5.0)4 (2–25)
JADAS10 >4.218 (n=42)1 (0–3)3.6 (0.0–10.0)1.9 (0.0–5.0)5 (2–31)
JADAS10 >16.419 (n=0)
Polyarticular disease
CID
JADAS10 ≤0.7 (n=52)0 (0)0.0 (0.0–0.6)0.0 (0.0–1.0)5 (1–18)
JADAS10 ≤1.018 (n=64)0 (0)0.0 (0.0–1.0)0.0 (0.0–1.0)5 (1–22)
JADAS10 ≤2.619 (n=89)0 (0–1)0.0 (0.0–2.6)0.0 (0.0–2.0)5 (1–33)
LDA
JADAS10 0.8–3.9 (n=60)0 (0–3)1.0 (0.0–4.0)0.5 (0.0–2.0)5 (1–33)
JADAS10 1.1–3.818 (n=39)0 (0–2)1.4 (0.0–3.7)0.5 (0.0–2.0)5 (1–33)
JADAS10 2.7–5.119 (n=23)1 (0–3)1.7 (0.0–4.4)1.0 (0.0–2.0)5 (2–21)
MDA10
JADAS10 4.0–15.2 (n=32)3 (0–8)3.8 (0.0–7.8)2.5 (0.0–4.0)8 (1–33)
JADAS10 3.9–10.518 (n=34)2 (0–6)2.6 (0.0–7.8)2.0 (0.0–4.0)7 (1–33)
JADAS10 5.1–18.919 (n=37)3 (0–10)4.0 (0.0–8.5)2.5 (0.0–5.0)1 (1–44)
HDA13
JADAS10 >15.2 (n=10)10 (3–15)4.6 (2.5–8.5)4.2 (3.0–8.0)8 (2–62)
JADAS10 >10.512 18 (n=17)7 (2–15)4.3 (1.5–8.5)3.0 (2.0–8.0)7 (2–62)
JADAS10 >18.919 (n=5)10 (7–15)4.3 (2.6–7.6)6.5 (3.0–8.0)16 (3–62)
  • AJC, active joint count; CID, clinically inactive disease; ESR, erythrocyte sedimentation rate; HDA, high disease activity; JADAS, Juvenile Arthritis Disease Activity Score; LDA, low disease activity; MDA, moderate disease activity; VAS, visual analogue scale.